Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-11-26
2000-10-24
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514546, 514557, 514870, A61K 3119
Patent
active
061368628
ABSTRACT:
A cerebral function improving agent containing as the active ingredient a compound represented by the following formula: ##STR1## wherein R.sub.2 represents a hydrogen atom when R.sub.1 is a hydroxyl group;
REFERENCES:
patent: 4346107 (1982-08-01), Cavazza et al.
patent: 5116868 (1992-05-01), Chen et al.
Chang et al., Can. J. Physiol. Pharmacol., "Hypoxia and beta-hydroxybutyrate acutely. reduce glucose extraction by the brain in anesthetized dogs," vol. 71, No. 7, pp. 465-472 (1993).
Robertson et al., Stroke, "Dietary nonprotein calories and cerebral infarction size in rats," vol. 23, No. 4, pp. 564-568 (1992).
Artru et al., J. of Neurochemistry, "gamma-hydroxybutyrate: cerebral metabolic, vascular, and protective effects," vol. 35 No. 5, pp. 1114-1119 (1980), (Abstract).
Bendikov et al., Biull. Eksp. Biol. Med., "Effect of sodium hydroxybutyrate on cerebral circulation and regional vasomotor reflexes," vol. 88, No. 11, pp. 555-557 (1979) Abstract No. 80154096 (Abstract).
Atarskaya et al., Kirg. Med. Inst., "Anti-oedematous agent for cerebral oedema experiments--comprises cobalt homo-pantothenato-ascorbinate, administered by intraperitoneal injection," Feb. 1994, (Abstract).
(Abstract), Denki Kagaku Kogyo KK, "Gamma amino beta hydroxybutyric acid preparation hydrolysis hydroxy pyrrolidon cerebral function metabolism adjust," Nov. 1982.
Owen et al., "Brain Metabolism During Fasting", The Journal of Clinical Investigation, vol. 46, No. 10, (1967), pp. 1585-1595.
Fuji et al., "Study on Administration of Ketone After Acute Cerebral Injury", Jpn. J. Acute Med., vol. 4, No. 5, (1993), pp. 484.
Go et al., "Protective Effect of Fasting Upon Cerebral Hypoxic-Ischemix Injury", Metabolic Brain Disease, vol. 3, No. 4, (1988), pp. 257-263.
Gueldry et al., "Effect of 1,3-Butaneodiol on Cerebral Energy Metabolism. Comparison With B-Hydroxybutyrate", Metabolic Brain Disease, vol. 9, No. 2, (1994), pp. 171-181.
Rising et al., "Hypoxia-Induced Increases in Hypoxic Tolerance Augmented by B-hydroxybutyrate in Mice", Stroke, vol. 20, No. 9, (1989), pp. 1219-1225.
Gueldry et al., "Changes in Extracellular and Rate Brain Tissue Concentrations of D-B-Hydroxybutyrate After 1,3-Butanediol Treatment", Journal of Neurochemistry, (1994), pp. 223-226.
Chang et al., "Hypoxia and B-Hydroxybutrate Acutely Reduce Glucose Extraction By the Brain in Anesthetized Dogs", Can. J. Physiol. Pharmacol., vol. 71, (1993), pp. 465-472.
Marie et al., "Protective Action of 1,3-Butanediol in Cerebral Ischemia. A Neurologic, Histologic, and Metabolic Study", Journal of Cerebral Blood Flow and Metabolism, vol. 7, (1987), pp. 794-800.
Kirsch et al., "Hypoxia Induced Preferential Ketone Utilization by Rat Brain Slices", Stroke, vol. 15, No. 2, (1984), pp. 319-323.
Kirsch et al., "Role of Tissue Lactate and Substrate Availability in 1,3-Butanediol-Enhanced Hypoxic Survival in the Mouse", Stroke, vol. 14, No. 6, (1983), pp. 971-976.
Roeder et al., "Competition Among Oxidizable Substrates in Brains of Young and Adult Rats", Biochem., J. vol. 219, (1984), pp. 125-130.
Seccombe et al., "Fetal Utilization of Maternally Derived Ketone Bodies for Lipogenesis in the Rat", Biochemica et Biophysica Acta, vol. 488, (1977), pp. 402-416.
Dohi Sekiko
Hiraide Atsushi
Shiba Yoshihiro
Suzuki Motohisa
MacMillan Keith D.
Shimizu Pharmaceutical Co., Ltd.
LandOfFree
Cerebral function improving agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cerebral function improving agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cerebral function improving agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1964682